Globus Medical (GMED) stock price, chart and financials

Price chart

Revenue (trailing twelve months)

$3.1B

Revenue (quarter)

$789.6M

Revenue growth (year over year)

+5.94%

Gross profit (trailing twelve months)

$2.2B

Gross margin

68.55%

Net income (trailing twelve months)

$535.4M

Net income (quarter)

$151.6M

Net income growth (year over year)

−25.28%

Net margin

17.03%

Return on equity

11.81%

EPS (trailing twelve months)

$3.97

Book value per share

$35.52

P/E (trailing twelve months)

19.12

Price to book

2.15

Debt to assets

13.11%

Payout ratio

—

Dividend yield

—

Company profile

Globus Medical Inc is a medical device company that develops and provides healthcare products and solutions to hospitals, physicians, and surgical centers. The firm's products are organized into two categories: musculoskeletal solutions, which include medical devices and instruments used mostly for spinal and orthopedic procedures, and enabling technologies, which include computer systems developed for enhancing surgical capabilities. The vast majority of the company's revenue is generated from musculoskeletal solutions products, and more than half of the revenue is earned in the United States. It also has its presence internationally.

• Is Globus Medical (GMED) profitable?

  Yes. Globus Medical earned $535.4M in net income over the trailing twelve months, a net margin of 17.03%.

• How much revenue does Globus Medical (GMED) make?

  Globus Medical generated $3.1B in revenue over the trailing twelve months, up 5.94% year over year.

• What is GMED's P/E ratio?

  Globus Medical trades at 19.1 times trailing twelve-month earnings, on an EPS of $3.97.

• How do I buy stock in Globus Medical (GMED)?

  GMED trades commission-free with a Light Horse Securities brokerage account — from the mobile app, the web at Light Horse Dashboard, the trading API, or an AI agent connected over MCP. The trade panel on this page places the order once you are signed in.